Updated Jul 16, 2026
Mesa Nilda has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $520K.

| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | UTHR | UNITED THERAPEUTICS Corp | M — Option exercise | 650 | $0.00 | |
| 2026-05-13 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale | 258 | $581.93 | $150K |
| 2025-07-24 | UTHR | UNITED THERAPEUTICS Corp | M — Option exercise | 590 | $0.00 | |
| 2025-06-24 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale | 645 | $289.99 | $187K |
| 2024-12-31 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale | 255 | $355.77 | $91K |
| 2024-11-12 | UTHR | UNITED THERAPEUTICS Corp | S — Open-market sale | 224 | $412.28 | $92K |
Mesa Nilda is a corporate insider — currently tracked as Insider of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($520K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mesa Nilda profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.